Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity.
Recently we have shown that post-exposure treatment with povidone iodine (PI) protects against nitrogen and sulfur mustard-induced skin lesions. Since proteolytic activity is involved in skin damage caused by chemical irritants, we have studied the effect of iodine on mechlorethamine (HN2)-induced skin collagenolytic activities in the haired guinea pig model. The matrix metalloproteinase-9 (MMP-9) activity increased by 30, 46, 12 and 23% after 3, 24, 48 and 72 h of HN2 exposure, respectively, whereas the MMP-2 was elevated by 8, 65, 8 and 30%, respectively. Topical treatment with PI at 15 and 120 min after HN2 exposure decreased the MMP-9 activity by 67% and 60%, respectively, when skin was analyzed 3 h after exposure. The same trend was observed in the MMP-2 and MMP-1 activities after PI treatment. A stronger effect of PI treatment 15 min following exposure was observed in skin analyzed 24 h after exposure, i.e. a decrease of 83% and 88% in MMP-9 and MMP-2 activities, respectively. Similar findings were observed with an interval of 120 min between HN2 exposure and PI treatment. A much weaker effect was observed on MMP-1 activity. A similar trend of PI-induced reduction in the three types of collagenase activity was found in skin analyzed 48 and 72 h after exposure. Reduced collagenolytic activity may serve as one of the mechanisms by which iodine protects the skin against chemical insult.
Wormser
Uri
U
Faculty of Sciences, Berman Building, The Hebrew University, Edmond Safra Campus, Givat Ram, 91904 Jerusalem, Israel. wormser@cc.huji.ac.il
Brodsky
Berta
B
Reich
Reuven
R
D000287:Administration, Topical; D000818:Animals; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007509:Irritants / Q000633:toxicity*; D008297:Male; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D008466:Mechlorethamine / Q000633:toxicity*; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects / Q000201:enzymology*; D012871:Skin Diseases / Q000139:chemically induced / Q000201:enzymology / Q000517:prevention & control*
D003879:Dermatologic Agents; D007509:Irritants; D008466:Mechlorethamine; D011206:Povidone-Iodine; D020782:Matrix Metalloproteinases